S. Di Paolo et al., Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF-beta 1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells, CLIN EXP IM, 117(2), 1999, pp. 355-360
Cyclosporin (CsA) is widely used in the treatment of renal disease and tran
splantation, which are often complicated by alterations of lipid metabolism
. Both chronic administration of CsA and hyperlipidaemia have been shown to
evoke an early macrophage influx and have progressively led to glomerular
and interstitial sclerosis. MCP-1 is the major monocyte chemoattractant sec
reted by stimulated mesangial cells and TGF-beta 1 is a key mediator of fib
rogenesis in chronic progressive renal fibrosis. Thus, the combined effect
of CsA and low-density lipoprotein (LDL) on the gene and protein expression
of MCP-1 and TGF-beta 1 in cultured human mesangial cells (HMC) was explor
ed. Both agents induced an early and persistent increase of MCP-1 and TGF-b
eta 1 mRNA levels and protein release. The simultaneous addition of CsA and
LDL did not display any additive effect on target gene expression, but it
caused a synergistic effect on MCP-1 and TGF-beta 1 protein secretion into
culture medium. On the other hand, CsA and LDL had different effects on cel
l proliferation: the latter increased DNA synthesis, whereas CsA inhibited
both spontaneous and mitogen-stimulated mesangial cell growth. The study co
ncludes that CsA and LDL display an additive effect on TGF-beta 1 and MCP-1
synthesis and release by HMC, thus possibly co-operating to induce an earl
y macrophage influx and the subsequent mesangial expansion and increased ex
tracellular matrix deposition. However, in contrast they seem to modulate H
MC proliferation differently, which is a further critical event intimately
involved in the development of glomerulosclerosis.